Piper Sandler Has Lowered Expectations for Vicarious Surgical (NYSE:RBOT) Stock Price

Vicarious Surgical (NYSE:RBOT) had its price objective lowered by Piper Sandler from $12.00 to $10.50 in a research report sent to investors on Wednesday morning,Benzinga reports. Piper Sandler currently has a neutral rating on the stock.

Vicarious Surgical Stock Performance

Shares of NYSE RBOT opened at $9.22 on Wednesday. Vicarious Surgical has a 52-week low of $4.27 and a 52-week high of $21.43. The firm has a market capitalization of $54.37 million, a price-to-earnings ratio of -0.90 and a beta of 1.02. The stock has a 50 day moving average price of $7.11 and a 200 day moving average price of $7.67.

About Vicarious Surgical

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.